Trial intelligence / Profile preview

Extended vs Traditional Letrozole for PCOS Ovulation Induction

NCT07159880Recruiting

Start
Sep 2025
Primary completion
Jul 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of letrozole in polycystic ovary syndrome (PCOS) and infertility (2 arms). Primary endpoint: Ovulation Rate up to 6 weeks. Started Sep 2025; status: recruiting.

02

Drugs

letrozole
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on NCT07159880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07159880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call